co2 Gap and co2/o2 Ratio in Liver Transplant Patients
co2gap
Use of the Venoarterial Carbon Dioxide Gap and Arteriovenous Oxygen Content to Guide the Resuscitation in the Liver Transplant Patients
1 other identifier
interventional
40
1 country
2
Brief Summary
finding surrogate to co to trace the effect of preload challenge would make the test more applicable without the need of advanced hemodynamic monitors,suggested that co2 gap can be used to detect FR after mini fluid challenge and fluid bolts .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 12, 2017
CompletedFirst Submitted
Initial submission to the registry
December 11, 2017
CompletedFirst Posted
Study publicly available on registry
December 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2018
CompletedMarch 29, 2018
March 1, 2018
11 months
December 11, 2017
March 27, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
co2gap
Difference between arterial and venous co2 gap
30 minuets after fluid bolus
Secondary Outcomes (1)
Stroke volume
Baseline 30 minutes after Icu admission, 1 minutes after mini fluid challenge , 30 minutes after fluid bolus
Study Arms (1)
CO2 gap
EXPERIMENTALThe patients will receive fluid bolus and observe changes in co2 gap and gap/ ratio in them.
Interventions
Eligibility Criteria
You may qualify if:
- patients post liver transplantation
- serum lactate \>2mmol/L
You may not qualify if:
- age less than 18 years
- patients with fulminant liver failure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Cairo University Medical School
Cairo, 11511, Egypt
Kasralainy hospital
Cairo, 11562, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed m Mukhtar, professor
kasrelainy medical school,cairo university,cairo,egypt
- STUDY CHAIR
Hassan kh Nagi, professor
kasrelainy medical school,cairo university,cairo,egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 11, 2017
First Posted
December 15, 2017
Study Start
June 12, 2017
Primary Completion
May 12, 2018
Study Completion
September 12, 2018
Last Updated
March 29, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share